Early trends in cystatin c and outcomes in patients with cirrhosis and acute kidney injury

International Journal of Nephrology

Volumn 2014, Issue , 2014, Pages

  Belcher, Justin M ^a,b   Sanyal, Arun J ^c   Garcia Tsao, Guadalupe ^a,b   Ansari, Naheed ^d   Coca, Steven G ^a,b   Shlipak, Michael G ^e   Parikh, Chirag R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JACOBI MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897479011     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2014/708585     Document Type: Article

References (30)

1. Arabi Y., Ahmed Q. A. A., Haddad S., Aljumah A., Al-Shimemeri A., Outcome predictors of cirrhosis patients admitted to the intensive care unit. European Journal of Gastroenterology and Hepatology 2004 16 3 333 339 2-s2.0-1642412728 (Pubitemid 38368379)
2. Cholongitas E., Calvaruso V., Senzolo M., Patch D., Shaw S., O'Beirne J., Burroughs A. K., RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. Journal of Gastroenterology and Hepatology 2009 24 10 1639 1647 2-s2.0-70349682755 10.1111/j.1440-1746.2009.05908.x
3. Francoz C., Glotz D., Moreau R., Durand F., The evaluation of renal function and disease in patients with cirrhosis. Journal of Hepatology 2010 52 4 605 613 2-s2.0-77949872872 10.1016/j.jhep.2009.11.025
4. Ustundag Y., Samsar U., Acikgoz S., Cabuk M., Kiran S., Kulah E., Aydemir S., Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Clinical Chemistry and Laboratory Medicine 2007 45 7 890 894 2-s2.0-34447249246 10.1515/CCLM.2007.130 (Pubitemid 47041878)
5. Cholongitas E., Marelli L., Kerry A., Senzolo M., Goodier D. W., Nair D., Thomas M., Patch D., Burroughs A. K., Different methods of creatinine measurement significantly affect MELD scores. Liver Transplantation 2007 13 4 523 529 2-s2.0-34247195052 10.1002/lt.20994 (Pubitemid 46605854)
6. Belcher J. M., Garcia-Tsao G., Sanyal A., Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 2012 57 2 753 762 10.1002/hep.25735
7. Soto K., Coelho S., Rodrigues B., Martins H., Frade F., Lopes S., Cunha L., Papoila A. L., Devarajan P., Cystatin C as a marker of acute kidney injury in the emergency department. Clinical Journal of the American Society of Nephrology 2010 5 10 1745 1754 2-s2.0-77958575826 10.2215/CJN.00690110
8. Herget-Rosenthal S., Marggraf G., Hüsing J., Göring F., Pietruck F., Janssen O., Philipp T., Kribben A., Early detection of acute renal failure by serum cystatin C. Kidney International 2004 66 3 1115 1122 2-s2.0-4344672550 10.1111/j.1523-1755.2004.00861.x (Pubitemid 39121017)
9. Nejat M., Pickering J. W., Walker R. J., Endre Z. H., Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrology Dialysis Transplantation 2010 25 10 3283 3289 2-s2.0-77957228221 10.1093/ndt/gfq176
10. Zappitelli M., Krawczeski C. D., Devarajan P., Wang Z., Sint K., Thiessen-Philbrook H., Li S., Bennett M. R., Ma Q., Shlipak M. G., Garg A. X., Parikh C. R., Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney International 2011 80 6 655 662 2-s2.0-80052268546 10.1038/ki.2011.123
11. Haase M., Bellomo R., Devarajan P., Ma Q., Bennett M. R., Möckel M., Matalanis G., Dragun D., Haase-Fielitz A., Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Annals of Thoracic Surgery 2009 88 1 124 130 2-s2.0-67649781612 10.1016/j.athoracsur.2009. 04.023
12. Haase-Fielitz A., Bellomo R., Devarajan P., Story D., Matalanis G., Dragun D., Haase M., Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Critical Care Medicine 2009 37 2 553 560 2-s2.0-67649761548 10.1097/CCM.0b013e318195846e
13. Bell M., Granath F., Mrtensson J., Löfberg E., Ekbom A., Martling C.-R., Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrology Dialysis Transplantation 2009 24 10 3096 3102 2-s2.0-70349488050 10.1093/ndt/gfp196
14. Briguori C., Visconti G., Rivera N. V., Focaccio A., Golia B., Giannone R., Castaldo D., De Micco F., Ricciardelli B., Colombo A., Cystatin C and contrast-induced acute kidney injury. Circulation 2010 121 19 2117 2122 2-s2.0-77953125953 10.1161/CIRCULATIONAHA.109.919639
15. Spahillari A., Parikh C. R., Sint K., Serum cystatin C-versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study. American Journal of Kidney Diseases 2012 60 6 922 929 10.1053/j.ajkd.2012.06.002
16. Hoek F. J., Kemperman F. A. W., Krediet R. T., A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrology Dialysis Transplantation 2003 18 10 2024 2031 2-s2.0-0141507021 10.1093/ndt/gfg349 (Pubitemid 37220307)
17. Gerbes A. L., Gülberg V., Bilzer M., Vogeser M., Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002 50 1 106 110 2-s2.0-0036135968 10.1136/gut.0500106. (Pubitemid 34028312)
18. Demirtaş S., Bozbaş A., Akbay A., Yavuz Y., Karaca L., Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clinica Chimica Acta 2001 311 2 81 89 2-s2.0-0035949750 10.1016/S0009-8981(01) 00546-0 (Pubitemid 32889693)
19. Chung M. Y., Jun D. W., Sung S. A., Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. The Korean Journal of Hepatology 2010 16 3 301 307 2-s2.0-79959517377
20. Erlandsen E. J., Randers E., Kristensen J. H., Evaluation of the dade behring N latex cystatin C assay on the dade behring nephelometer II system. Scandinavian Journal of Clinical and Laboratory Investigation 1999 59 1 1 8 2-s2.0-0033003668 (Pubitemid 29133539)
21. Wong F., Nadim M. K., Kellum J. A., Salerno F., Bellomo R., Gerbes A., Angeli P., Moreau R., Davenport A., Jalan R., Ronco C., Genyk Y., Arroyo V., Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011 60 5 702 709 2-s2.0-79953749879 10.1136/gut.2010.236133
22. Levey A. S., Stevens L. A., Schmid C. H., Zhang Y., Castro A. F. III, Feldman H. I., Kusek J. W., Eggers P., Lente F. V., Greene T., Coresh J., A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009 150 9 604 612 2-s2.0-65649142017
23. Dobre M., Demirjian S., Sehgal A. R., Navaneethan S. D., Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. International Urology and Nephrology 2011 43 1 175 184 2-s2.0-79953808409 10.1007/s11255-010- 9725-8
24. Davenport A., Difficulties in assessing renal function in patients with cirrhosis: potential impact on patient treatment. Intensive Care Medicine 2011 37 6 930 932 2-s2.0-79959733989 10.1007/s00134-011-2161-0
25. Pöge U., Gerhardt T., Stoffel-Wagner B., Klehr H. U., Sauerbruch T., Woitas R. P., Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients. Nephrology Dialysis Transplantation 2006 21 3 660 664 2-s2.0-33644863016 10.1093/ndt/gfi305 (Pubitemid 43372911)
26. Demirtaş S., Bozbaş A., Akbay A., Yavuz Y., Karaca L., Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clinica Chimica Acta 2001 311 2 81 89 2-s2.0-0035949750 10.1016/S0009-8981(01) 00546-0 (Pubitemid 32889693)
27. Ahn H. S., Kim Y. S., Kim S. G., Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels. Hepatogastroenterology 2012 59 116 1168 1173
28. Hall I. E., Doshi M. D., Poggio E. D., Parikh C. R., A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation. Transplantation 2011 91 1 48 56 2-s2.0-78751662129 10.1097/TP.0b013e3181fc4b3a
29. Kwon S. H., Hyun J., Jeon J. S., Noh H., Han D. C., Subtle change of cystatin C, with or without acute kidney injury, associated with increased mortality in the intensive care unit. Journal of Critical Care 2011 26 6 566 571 2-s2.0-81955163075 10.1016/j.jcrc.2011.01.004
30. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., Malyszko J. S., Poniatowski B., Pawlak K., Dobrzycki S., NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? International Journal of Cardiology 2008 127 2 290 291 2-s2.0-44849134806 10.1016/j.ijcard.2007.04.048 (Pubitemid 351795614)